RESUMO
This case report describes a patient in their 60s with gastroesophageal reflex disease who presented to the emergency department after loss of consciousness during dinner and daily intermittent chest discomfort.
Assuntos
Arritmias Cardíacas , Síncope , Humanos , Síncope/diagnóstico , Síncope/etiologiaRESUMO
Since the nationally televised cardiac arrest of American National Football League player Damar Hamlin in January 2023, commotio cordis has come to the forefront of public attention. Commotio cordis is defined as sudden cardiac arrest due to direct trauma to the precordium resulting in ventricular fibrillation or ventricular tachycardia. While the precise incidence of commotio cordis is not known due to a lack of standardized, mandated reporting, it is the third most common cause of sudden cardiac death in young athletes, with more than 75% of cases occurring during organized and recreational sporting events. Given that survival is closely tied to how quickly victims receive cardiopulmonary resuscitation and defibrillation, it is crucial to raise awareness of commotio cordis so that athletic trainers, coaches, team physicians, and emergency medical personnel can rapidly diagnose and treat this often-fatal condition. Broader distribution of automated external defibrillators in sporting facilities as well as increased presence of medical personnel during sporting events would also likely lead to higher survival rates.
Assuntos
Reanimação Cardiopulmonar , Commotio Cordis , Futebol Americano , Humanos , Commotio Cordis/terapia , Commotio Cordis/diagnóstico , Commotio Cordis/etiologia , Reanimação Cardiopulmonar/efeitos adversos , Reanimação Cardiopulmonar/métodos , Morte Súbita Cardíaca/etiologia , Morte Súbita Cardíaca/prevenção & controle , Arritmias CardíacasAssuntos
Bradicardia/terapia , Doença do Sistema de Condução Cardíaco/terapia , Estimulação Cardíaca Artificial , Bradicardia/diagnóstico , Doença do Sistema de Condução Cardíaco/diagnóstico , Doença do Sistema de Condução Cardíaco/etiologia , Gerenciamento Clínico , Humanos , Síndromes da Apneia do Sono/complicaçõesAssuntos
American Heart Association , Cardiologia , Comitês Consultivos , Bradicardia , Humanos , Sociedades , Estados UnidosAssuntos
Bradicardia , Doença do Sistema de Condução Cardíaco , Terapia de Ressincronização Cardíaca/métodos , Procedimentos Cirúrgicos Cardíacos , Fármacos Cardiovasculares/farmacologia , Técnicas Eletrofisiológicas Cardíacas/métodos , Qualidade de Vida , American Heart Association , Bradicardia/etiologia , Bradicardia/fisiopatologia , Bradicardia/terapia , Doença do Sistema de Condução Cardíaco/etiologia , Doença do Sistema de Condução Cardíaco/fisiopatologia , Doença do Sistema de Condução Cardíaco/terapia , Procedimentos Cirúrgicos Cardíacos/efeitos adversos , Procedimentos Cirúrgicos Cardíacos/métodos , Frequência Cardíaca/efeitos dos fármacos , Frequência Cardíaca/fisiologia , Humanos , Administração dos Cuidados ao Paciente/métodos , Seleção de Pacientes , Guias de Prática Clínica como Assunto , Estados UnidosAssuntos
Bradicardia , Doença do Sistema de Condução Cardíaco , Terapia de Ressincronização Cardíaca/métodos , Procedimentos Cirúrgicos Cardíacos , Fármacos Cardiovasculares/farmacologia , Técnicas Eletrofisiológicas Cardíacas/métodos , Qualidade de Vida , American Heart Association , Bradicardia/etiologia , Bradicardia/fisiopatologia , Bradicardia/terapia , Doença do Sistema de Condução Cardíaco/etiologia , Doença do Sistema de Condução Cardíaco/fisiopatologia , Doença do Sistema de Condução Cardíaco/terapia , Procedimentos Cirúrgicos Cardíacos/efeitos adversos , Procedimentos Cirúrgicos Cardíacos/métodos , Frequência Cardíaca/efeitos dos fármacos , Frequência Cardíaca/fisiologia , Humanos , Administração dos Cuidados ao Paciente/métodos , Seleção de Pacientes , Estados UnidosAssuntos
Bradicardia/diagnóstico , Doença do Sistema de Condução Cardíaco/diagnóstico , Agonistas Adrenérgicos beta/uso terapêutico , Algoritmos , Bradicardia/genética , Bradicardia/terapia , Broncodilatadores/uso terapêutico , Bloqueadores dos Canais de Cálcio/uso terapêutico , Doença do Sistema de Condução Cardíaco/genética , Doença do Sistema de Condução Cardíaco/terapia , Cardiotônicos/uso terapêutico , Eletrocardiografia/métodos , Testes Genéticos/métodos , HumanosAssuntos
Bradicardia/diagnóstico , Doença do Sistema de Condução Cardíaco/diagnóstico , Antagonistas Adrenérgicos beta/uso terapêutico , Arritmias Cardíacas/etiologia , Bradicardia/complicações , Bradicardia/epidemiologia , Bradicardia/terapia , Doença do Sistema de Condução Cardíaco/complicações , Doença do Sistema de Condução Cardíaco/epidemiologia , Doença do Sistema de Condução Cardíaco/terapia , Eletrocardiografia , Fenômenos Eletrofisiológicos , Epilepsia/complicações , Cardiopatias/complicações , Cardiopatias/congênito , Humanos , Infarto do Miocárdio/complicações , Qualidade de VidaRESUMO
BACKGROUND: Remote wireless follow-up of implanted pacemakers (PM) has become an attractive method of follow-up. Although wireless PM follow-up has several advantages compared with transtelephonic and office-based follow-up, its utility depends on successful transmission. HYPOTHESIS: Initial in-office setup of wireless PM will improve transmission rate as compared with home setup. METHODS: A total of 202 consecutive patients from 2 medical centers were included in this retrospective study. Patients in the home setup group (N = 101) had traditional home setup of wireless PM, whereas patients in the in-office group (N = 101) had setup of PMs by allied health professionals during the postoperative office visit. Successful transmission was defined as successful initial wireless transmission of PM data by 2 months postimplant. RESULTS: Of the 101 patients in the home setup group, 22 (22%) patients had successful transmission. Of the 101 patients in the in-office group, 92 (91%) patients had successful transmission (P < 0.0001). Logistic regression analysis showed that that the in-office group was independently associated with successful transmission (odds ratio: 114.5; 95% confidence interval: 32.1-408.4; P < 0.0001). CONCLUSIONS: In patients implanted with PM capable of remote wireless data transmission, initial home setup of the wireless monitoring device was frequently unsuccessful. In-office PM setup was associated with a significantly higher rate of successful transmission.
Assuntos
Arritmias Cardíacas/terapia , Estimulação Cardíaca Artificial , Visita a Consultório Médico , Marca-Passo Artificial , Telemedicina/métodos , Telemetria , Tecnologia sem Fio , Idoso , Idoso de 80 Anos ou mais , Arritmias Cardíacas/diagnóstico , California , Distribuição de Qui-Quadrado , Feminino , Humanos , Modelos Logísticos , Masculino , Pessoa de Meia-Idade , Razão de Chances , Valor Preditivo dos Testes , Estudos Retrospectivos , Processamento de Sinais Assistido por Computador , Resultado do TratamentoRESUMO
Despite the increased risk of myocardial infarction, aortic dissection, and arrhythmias in patients with hypertension who use cocaine, the hemodynamic and arrhythmogenic effects of cocaine use have not been well characterized in this population. The authors hypothesized that patients with hypertension demonstrate extreme, transient changes in arterial pressures as well as new arrhythmic activity during cocaine use. Ambulatory blood pressures, heart rates, and electrocardiograms (AECGs) were recorded for 48 hours in 10 patients with a history of hypertension who smoke cocaine. Active cocaine use was identified through patient diaries and manual activation of the blood pressure cuff. Of the 10 patients studied (6 men, 7 African Americans, age 49±8 years), 8 were taking antihypertensive medications. The mean blood pressure prior to cocaine use was 126/77 mm Hg and average increase in systolic, diastolic, and mean arterial pressure after use was 74 mm Hg, 30 mm Hg, and 45 mm Hg, respectively (P<.0001 for all). There was no significant change in heart rate. AECGs demonstrated arrhythmic activity during cocaine use, including 6 patients with increased atrial and ventricular ectopy, 2 patients with episodes of nonsustained atrial tachycardia, and 1 patient with 3 episodes of nonsustained monomorphic ventricular tachycardia. Cocaine use resulted in extreme elevations in arterial pressures in patients with hypertension taking medication. Cocaine use was also associated with an increase in arrhythmic activity. These findings may underlie the heightened risk of myocardial infarction, aortic dissection, and potentially lethal arrhythmias in patients with hypertension who use cocaine.
Assuntos
Pressão Sanguínea/efeitos dos fármacos , Cocaína/farmacologia , Eletrocardiografia , Frequência Cardíaca/efeitos dos fármacos , Hipertensão/fisiopatologia , Vasoconstritores/farmacologia , Adulto , Anti-Hipertensivos/uso terapêutico , Doenças da Aorta/epidemiologia , Arritmias Cardíacas/epidemiologia , Pressão Sanguínea/fisiologia , Monitorização Ambulatorial da Pressão Arterial , Feminino , Frequência Cardíaca/fisiologia , Humanos , Hipertensão/tratamento farmacológico , Masculino , Pessoa de Meia-Idade , Infarto do Miocárdio/epidemiologia , Estudos Prospectivos , Estudos Retrospectivos , Fatores de RiscoRESUMO
The National Heart, Lung, and Blood Institute convened an expert panel April 28 to 29, 2008, to identify gaps and recommend research strategies to prevent atrial fibrillation (AF). The panel reviewed the existing basic scientific, epidemiological, and clinical literature about AF and identified opportunities to advance AF prevention research. After discussion, the panel proposed the following recommendations: (1) enhance understanding of the epidemiology of AF in the population by systematically and longitudinally investigating symptomatic and asymptomatic AF in cohort studies; (2) improve detection of AF by evaluating the ability of existing and emerging methods and technologies to detect AF; (3) improve noninvasive modalities for identifying key components of cardiovascular remodeling that promote AF, including genetic, fibrotic, autonomic, structural, and electrical remodeling markers; (4) develop additional animal models reflective of the pathophysiology of human AF; (5) conduct secondary analyses of already-completed clinical trials to enhance knowledge of potentially effective methods to prevent AF and routinely include AF as an outcome in ongoing and future cardiovascular studies; and (6) conduct clinical studies focused on secondary prevention of AF recurrence, which would inform future primary prevention investigations.
Assuntos
Fibrilação Atrial/epidemiologia , Fibrilação Atrial/prevenção & controle , National Heart, Lung, and Blood Institute (U.S.) , Animais , Humanos , Fatores de Risco , Estados UnidosRESUMO
STUDY OBJECTIVE: Numerous investigators have evaluated the ECG algorithm described by Sgarbossa et al to predict acute myocardial infarction in the presence of left bundle branch block and have arrived at divergent conclusions. To clarify the utility of the Sgarbossa ECG algorithm, we perform a systematic review and meta-analysis of these trials. METHODS: A structured search was applied to MEDLINE and Scopus databases, beginning with the year that the algorithm was derived (1996). Two reviewers independently screened citations, assessed for method quality, and extracted data (individual study characteristics, screening performance, and interobserver agreement) with a standardized extraction tool. We assessed qualifying studies for heterogeneity and generated summary estimates for the sensitivity, specificity, and positive and negative likelihood ratios with fixed-effect models. RESULTS: We identified 11 studies with 2,100 patients that met criteria for at least 1 component of the analysis. Ten studies with 1,614 patients reported a Sgarbossa ECG algorithm score of greater than or equal to 3. These yielded a summary sensitivity of 20% (95% confidence interval [CI] 18% to 23%), specificity of 98% (95% CI 97% to 99%), a positive likelihood ratio of 7.9 (95% CI 4.5 to 13.8), and a negative likelihood ratio of 0.8 (95% CI 0.8 to 0.9). The summary diagnostic odds ratio revealed homogeneity. Seven studies with 1,213 patients reported a Sgarbossa ECG algorithm score of greater than or equal to 2. These yielded sensitivities ranging from 20% to 79% and specificities ranging from 61% to 100%. Positive likelihood ratios ranged from 0.7 to 6.6 and negative likelihood ratios ranged from 0.2 to 1.1. The summary diagnostic odds ratio revealed heterogeneity. Intra- and interobserver agreement was substantial. Sensitivity analysis using the highest-quality studies yielded similar results. CONCLUSION: A Sgarbossa ECG algorithm score of greater than or equal to 3, representing greater than or equal to 1 mm of concordant ST elevation or greater than or equal to 1 mm ST depression in leads V1 to V3, is useful for diagnosing acute myocardial infarction in patients who present with left bundle branch block on ECG. The scoring system demonstrates good to excellent overall interobserver variability. A score of 2, representing 5 mm or more of discordant ST deviation, demonstrated ineffective positive likelihood ratios. A Sgarbossa ECG algorithm score of 0 is not useful in excluding acute myocardial infarction.
Assuntos
Bloqueio de Ramo/complicações , Eletrocardiografia , Infarto do Miocárdio/complicações , Infarto do Miocárdio/diagnóstico , Algoritmos , Intervalos de Confiança , Feminino , Humanos , Masculino , Variações Dependentes do ObservadorRESUMO
The Brugada syndrome is an arrhythmogenic disease with characteristic coved ST-segment elevation 2 mm or greater in the right precordial leads (type 1 Brugada electrocardiogram [ECG] pattern or "Brugada sign"] and is estimated to be responsible for at least 20% of sudden deaths in patients with structurally normal hearts [Circulation 2005;111(5):659-70]. The Brugada sign has been described in asymptomatic patients after exposure to various drugs. As published reports of the drug-induced Brugada sign have become increasingly prevalent, there is growing interest in the mechanisms responsible for this acquired ECG pattern and its clinical significance. We report a case of a patient who developed the type 1 Brugada ECG pattern after intentional overdose of a tricyclic antidepressant agent, review the literature concerning tricyclic antidepressant agent-induced Brugada sign, discuss potential mechanisms, and evaluate the clinical significance of this ECG abnormality.